Active	Status	Sponsor type	Region	Phase	Filter
16 Active 7 Inactive 23 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Gray, Jhanelle
NCT06745882: Prospective Trial Assessing Real World Outcomes Response to Pembro in Black Patients w/ NSCLC	Not yet recruiting	2	318	US	Cisplatin, Carboplatin, Pemetrexed, Pembrolizumab, Abraxane, Paclitaxel	H. Lee Moffitt Cancer Center and Research Institute, Merck Sharp & Dohme LLC, Foundation Medicine, Go-2 Lung	Non-small Cell Lung Cancer	01/30	01/30
NCT02638090: Pembro and Vorinostat for Patients With Stage IV Non-small Cell Lung Cancer (NSCLC)	Active, not recruiting	1/2	124	US	Vorinostat, Zolinza, Pembrolizumab, KEYTRUDA	H. Lee Moffitt Cancer Center and Research Institute, Merck Sharp & Dohme LLC	Lung Cancer, Non-small Cell Lung Cancer	01/24	01/26
NCT04610658: Immune Checkpoint Inhibition With Lurbinectedin Relapsed/Recurrent SCLC	Terminated	1	9	US	Nivolumab, Opdivo, Ipilimumab, Yervoy, Lurbinectedin	H. Lee Moffitt Cancer Center and Research Institute, Bristol-Myers Squibb, Jazz Pharmaceuticals	Small-cell Lung Cancer, Relapsed Small Cell Lung Cancer, Recurrent Small Cell Lung Cancer	03/23	03/23
Lima, Diana S
No trials found